Skip to content
Search AI Powered

Latest Stories

FDA finds Indian company's eye drops that caused deaths violated safety norms

EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears, manufactured in India by Global Pharma, have been associated with a fatal outbreak of drug-resistant infections in the US

FDA finds Indian company's eye drops that caused deaths violated safety norms

According to the top regulator in the US, the manufacturer of eye drops based in India, which has been linked to three deaths and severe infections, had breached multiple safety regulations.

The Food and Drug Administration (FDA) conducted an inspection of Global Pharma's facility in Chennai, India, and released a report last week.


The company recalled the eye drops in February after a recommendation from the FDA. The FDA also banned the import of the product.

Two brands of eye drops – EzriCare Artificial Tears and Delsam Pharma's Artificial Tears, which were manufactured in India by Global Pharma and imported to the US, have been associated with a fatal outbreak of drug-resistant infections in the US.

In March, the Centres for Disease Control and Prevention (CDC) in the US reported that 68 individuals across 16 states had been diagnosed with a rare type of Pseudomonas aeruginosa, which can lead to severe infections, particularly in people with weakened immune systems.

This drug-resistant strain had not been discovered in the US prior to the most recent epidemic.

As per the BBC report in March, besides the fatalities, eight patients experienced a loss of vision, while four had to undergo eye surgery to remove their eye.

In February, EzriCare Artificial Tears stated on its website that they had been contacting customers to discourage them from using the product, to the best of their abilities.

However, the company claimed to not be involved in the actual production of the eye drops, despite marketing them.

Initially, the recall was limited to EzriCare Artificial Tears Lubricant and Delsam Pharma Artificial Tears Lubricant eye drops, but it was subsequently expanded to include a Delsam Pharma eye ointment.

Additionally, according to the agency's report, during an 11-day inspection of the Global Pharma plant in India, which started on February 20, the FDA identified multiple infringements of sterilisation and hygiene protocols.

The sterile manufacturing environment had several items that were not adequately cleaned, including a bowl with a greasy deposit.

The FDA's report also stated that surfaces that came into touch with drug packaging were not appropriately cleaned, decontaminated, sanitised or sterilised.

The CDC also expressed concern that the bacteria associated with the contaminated eye drops could establish itself in the US healthcare system, a report in The New York Times on Monday (03) informed.

The CDC had previously advised individuals who had used the recalled products and were experiencing symptoms to consult a physician.

Symptoms included a discharge from the eye that was yellow, green, or clear, discomfort or pain, redness, blurry vision, and heightened sensitivity to light.

More For You

Exclusive: 'Starmer must fill NHS staffing defecit'
Dr Chaand Nagpaul

Exclusive: 'Starmer must fill NHS staffing defecit'

LABOUR's latest announcement to cut NHS waiting lists, while welcome, does not go far enough, the former leader of the doctors’ union, Chaand Nagpaul has told Eastern Eye.

Prime minister, Sir Keir Starmer, unveiled his plans on Monday (6). He pledged Labour would set up more NHS hubs in community locations in England, and the service would make greater use of the private sector to help meet the challenge.

Keep ReadingShow less
Exclusive: 'Stop spreading racial hatred'
Nazir Afzal

Exclusive: 'Stop spreading racial hatred'

POLITICIANS must dial down “dangerous and inflammatory” rhetoric and recognise the contributions of all communities in Britain, prominent south Asians have told Eastern Eye.

They are concerned that recent social media attacks on asylum seekers, immigrants, especially British Pakistanis, as well as ministers will lead to unnecessary deaths.

Keep ReadingShow less
Lisa-Nandy-Getty

The culture secretary retains powers to refer the case to the Competition and Markets Authority, which could trigger an investigation into press freedom concerns linked to Abu Dhabi’s involvement. (Photo: Getty Images)

Calls grow for Lisa Nandy to end Telegraph ownership stalemate

THE SALE of The Telegraph newspaper has drawn widespread political calls for culture secretary Lisa Nandy to intervene and end the prolonged uncertainty surrounding its ownership.

The newspaper has been in limbo for 20 months after an auction process initiated by RedBird IMI, an Abu Dhabi-backed investment fund, failed to secure a suitable buyer.

Keep ReadingShow less
illegal-migrants-getty

According to government data, over 36,800 people crossed the Channel in 2024. (Photo: Getty Images)

Getty Images

Labour government reports highest illegal migrant removals since 2018

THE LABOUR government announced on Thursday that it had removed 16,400 illegal migrants since taking office in July, the fastest rate of removals since 2018.

On taking office, prime minister Keir Starmer scrapped the previous Conservative government's scheme to send migrants who arrive illegally to Rwanda, instead setting up a Border Security Command to crack down on illegal migration – a huge political issue in Britain.

Keep ReadingShow less
Two men jailed for trying to smuggle migrants into UK

Shafaz Khan (L), Choudhry Rashied (Photo: Home Office)

Two men jailed for trying to smuggle migrants into UK

TWO London-based men have been sentenced to over 10 years behind bars after being convicted of breaching UK immigration law by trying to smuggle four Indian migrants in a hidden van compartment disguised by a stack of dirty tyres.

According to the UK Home Office, British nationals Shafaz Khan and Choudhry Rashied, who operated under the alias ‘Manzar Mian Attique’, hid the group of migrants behind the tyres in a “purpose built” hidden space in the vehicle.

Keep ReadingShow less